Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
AI unexpectedly uncovers potential antibiotics in prion proteins
2+ hour, 28+ min ago (127+ words) New antibiotic candidates may reside inside prions, misfolded proteins best known for rare and fatal degenerative brain diseases....
Application Note: Optimizing alternative vessel formats for transient protein production in the Expi293 PRO Expression System
1+ mon, 2+ week ago (0+ words) ...
AI & Antibodies mini-series | Balancing binding affinity and therapeutic practicality
1+ mon, 2+ week ago (21+ words) This episode of our series on AI & Antibodies explores the use of AI in the prediction of Antibody Binding Affinity...
AI & Antibodies mini-series | An artificial approach to humanization
1+ mon, 3+ week ago (1015+ words) Antibody humanization presents a major challenge in antibody therapeutic development, but how could AI help resolve it?...
Capturing true single-cell resolution with your spatial data
2+ mon, 3+ week ago (19+ words) In this interview, find out how to capture true single-cell spatial data, including tips for conducting spatial analyses....
A 'lightbulb moment': AI-designed intrabody probes track activity inside living cells
6+ mon, 6+ day ago (725+ words) Original story from Colorado State University (CO, USA). AI tools expedite antibody probe development, allowing researchers to track activity inside living cells. Researchers at Colorado State University (CSU; CO, USA) have determined how to use artificial intelligence to modify antibodies…...
The biotech bi-weekly: a 48-channel SPR platform, robust RNA-seq libraries and microgravitational discoveries
5+ mon, 1+ week ago (31+ words) Extracting low-abundance, circulating cell-free DNA, addressing a critical bottleneck in early stage oncology drug discovery and the unveiling of an AI for supporting drug discovery. Over the last 2......
Generating novel antibiotic candidates with SyntheMol-RL
2+ mon, 4+ week ago (22+ words) A new AI model that can generate structurally novel antibiotic candidates that are easy to develop in the lab has been unveiled....
Accelerating antibody development with a novel platform
10+ mon, 3+ week ago (301+ words) Original story from the University of Illinois Urbana–Champaign (IL, USA). The oPool+ display platform combines technologies to make and test large numbers of antibodies at once. Dubbed the oPool+ display, the method they developed could drastically accelerate antibody research…...